CD74: a new prognostic factor for patients with malignant pleural mesothelioma

BACKGROUND: The pro-inflammatory cytokine migration inhibitory factor (MIF) and its receptor CD74 have been proposed as possible therapeutic targets in several cancers. We studied the expression of MIF and CD74 together with calretinin in specimens of malignant pleural mesothelioma (MPM), correlatin...

Descripción completa

Detalles Bibliográficos
Autores principales: Otterstrom, C, Soltermann, A, Opitz, I, Felley-Bosco, E, Weder, W, Stahel, R A, Triponez, F, Robert, J H, Serre-Beinier, V
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3992494/
https://www.ncbi.nlm.nih.gov/pubmed/24594996
http://dx.doi.org/10.1038/bjc.2014.117

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3992494/
https://www.ncbi.nlm.nih.gov/pubmed/24594996
http://dx.doi.org/10.1038/bjc.2014.117

Ejemplares similares